Research·2026-07-12·13 min read

Italy's Migraine Care System Is Failing Patients — A New Consensus Plan Aims to Fix It

A new Italian consensus effort exposes deep gaps in how migraine is diagnosed and treated across primary and specialist care — and outlines a structured roadmap to help more patients get the right care, faster.

By Editorial Team
Link Copied!

Key Takeaways

  • Migraine is widely recognized as a disabling neurological disorder, yet only a minority of people with the condition receive a timely, correct diagnosis.
  • Most migraine patients are first seen in general practice, but the pathway from a primary care visit to specialist treatment is often poorly defined or delayed.
  • Italian clinicians and researchers worked toward a formal consensus on best-practice guidelines to standardize care across the full patient journey.
  • The initiative focused specifically on optimizing how patients move from general practitioners to specialist neurological care.
  • Fragmented management — not just the disease itself — is a core driver of poor outcomes in migraine populations.

For most people who live with migraine, the path to proper care is rarely a straight line. It winds through rushed primary care appointments, misdiagnoses of tension headache or stress, years of over-the-counter medications that don't quite work, and a specialist waitlist that can stretch for months. By the time a neurologist finally sees them, many patients have already developed more severe or chronic forms of the condition.

This is not a story unique to any one country — but Italy has taken a formal step to confront it head-on. A new consensus initiative, led by migraine clinicians and researchers across the Italian healthcare system, set out to map the problem and build practical, evidence-informed pathways that could finally align how general practitioners and specialists work together to manage one of the world's most prevalent and debilitating neurological disorders.

The result is a consensus document — the product of deliberate collaboration — aimed at improving the entire patient journey: from the first mention of head pain in a primary care office to the nuanced, preventive management strategies available only in specialist settings. Understanding what this effort found, and why it was necessary, offers a window into a much larger global problem in migraine care.

The Scale of Migraine — and the Scale of Mismanagement

Migraine is not a bad headache. It is a complex, recurring neurological disorder characterized by moderate-to-severe head pain — often one-sided and throbbing — that can be accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Attacks can last anywhere from four hours to three days, and for people with chronic migraine, episodes occur on 15 or more days per month.

Migraine by the Numbers

1 in 7
People globally estimated to experience migraine
Minority
Of migraine sufferers who receive a timely, correct diagnosis
3rd most
Prevalent illness in the world, according to the Global Burden of Disease study
Years
Average delay many patients experience between symptom onset and appropriate treatment

Despite this burden, migraine remains one of the most undertreated neurological conditions in the world. Globally, surveys consistently show that large proportions of people with migraine are either undiagnosed, misdiagnosed, or receiving treatments that are not suited to their disease profile. The Italian consensus initiative identified this mismanagement as a defining feature of the current landscape — a systemic problem rather than a collection of individual clinical missteps.

The reasons for widespread mismanagement are multiple and interlocking. Migraine overlaps symptomatically with several other conditions, including tension-type headache, cluster headache, and medication overuse headache. Primary care physicians — who are typically the first point of contact for patients — often receive limited training in headache disorders during medical education. And in many healthcare systems, access to neurologists with headache expertise is constrained by appointment availability, referral barriers, and geography.

Key Finding

Only a minority of individuals with migraine receive a timely, correct diagnosis and appropriate treatment — a gap this Italian consensus initiative was specifically designed to close.

The consensus effort focused on the entire patient journey, from general practice through to specialist neurological care.

Why Consensus Efforts Matter in Complex Disease Management

In medicine, a formal consensus process is used when the evidence base alone cannot resolve clinical uncertainty — or when high-quality evidence exists but has not been consistently translated into practice. Migraine is a condition where both problems apply simultaneously. There are effective diagnostic criteria, well-established acute treatments, and an expanding toolkit of preventive therapies. Yet the gap between what is possible in optimal care and what actually happens in the average clinical encounter remains stubbornly wide.

Consensus guidelines, when developed rigorously and with broad stakeholder input, serve as bridges. They synthesize existing evidence, layer in clinical experience, and produce actionable recommendations that individual practitioners can apply without needing to parse the entire research literature independently. In a healthcare system as regionally diverse as Italy's — where care quality and specialist access can vary substantially between northern and southern regions, and between urban centers and rural communities — a national consensus framework carries particular weight.

The Italian initiative specifically targeted the interface between two levels of care: the general practitioner (GP) setting, where most migraine patients are first encountered, and the specialist neurology or headache center setting, where more complex cases are evaluated and managed. This boundary — the handoff zone between primary and specialist care — is where many patients fall through the cracks.

Mapping the Patient Journey: Where the System Breaks Down

To understand what the Italian consensus was trying to fix, it helps to trace the typical journey of a person with migraine through the healthcare system. The experience is telling.

The Primary Care Encounter

Most people who experience recurring headaches do not immediately seek medical care. They self-treat, often for years, using over-the-counter analgesics. When they do eventually present to a GP, the consultation may be brief, and the complaint of 'headaches' may not immediately trigger a structured diagnostic assessment. Without screening tools or established protocols, primary care physicians may reassure the patient, prescribe a simple pain reliever, and move on.

This is not negligence — it reflects the structural reality of primary care, where time is limited, patient lists are long, and headache disorders have not historically been prioritized in training curricula. But the consequence is that patients with true migraine — a condition with specific, effective treatments — may spend years receiving inadequate management.

The Referral Gap

Even when a GP suspects migraine and considers referring a patient to a neurologist or headache specialist, the pathway is not always clear. Referral criteria — the specific clinical indicators that should prompt escalation to specialist care — are often informal or inconsistently applied. Patients may be referred too late, after their episodic migraine has progressed to a chronic form, or not at all. Others may be referred unnecessarily for straightforward cases that could be managed competently in primary care with better tools and training.

At the specialist end, headache centers and neurologists often receive patients who arrive without a clear prior diagnosis, without a structured headache diary, and without a record of treatments already tried. This duplication of effort slows the diagnostic process and delays the initiation of appropriate therapy.

The Hidden Cost of Delayed Diagnosis

Migraine that progresses from episodic to chronic — defined as 15 or more headache days per month — is significantly harder to treat and carries a much greater burden for the patient. Early, correct diagnosis and treatment are associated with better long-term outcomes, making the delays identified in this consensus effort not merely inconvenient but clinically consequential.

What the Consensus Process Was Designed to Achieve

The Italian consensus initiative had a clear and focused aim: to establish shared, evidence-based indications for improving how migraine patients are managed, and to optimize the transition between primary and specialist care. This is a more targeted goal than producing a comprehensive migraine treatment guideline — it is specifically about the system of care, not just the clinical content of that care.

Consensus-building in medicine typically involves assembling a group of clinical experts — in this case, drawn from across Italy's migraine and headache medicine community — and using structured methods to reach agreement on questions where clinical practice varies or where formal guidance is lacking. The result is a set of recommendations that carry the collective endorsement of the participating experts, lending them authority beyond what any single practitioner's opinion could provide.

The focus on 'best practices across primary and specialist care' signals that the initiative was not designed to simply produce another specialist guideline that GPs would be expected to implement without support. Rather, the goal was to produce recommendations that make sense at every level of the care pathway — from the first GP appointment to ongoing management in a headache center.

The Broader Problem: Migraine Is Still Not Taken Seriously Enough

One thread running through the rationale for this initiative is the persistent undervaluation of migraine as a clinical priority. Despite being one of the leading causes of years lived with disability worldwide — ranking above most other neurological conditions in terms of the disability burden it produces — migraine has historically received less research funding, less clinical attention, and less policy focus than conditions with comparable impact.

Part of the problem is stigma. Migraine is sometimes perceived — by members of the public, employers, and even some healthcare providers — as a form of exaggerated headache, rather than as a serious neurological disease with identifiable biological mechanisms. This perception shapes how patients are treated when they seek care, and it shapes how healthcare systems allocate resources for headache disorders.

The Italian consensus effort is, in part, a corrective to this undervaluation. By formalizing best practices and establishing clear expectations for how migraine should be managed at both the primary and specialist level, it positions migraine as a condition that demands — and deserves — systematic, structured clinical attention.

Primary Care vs. Specialist Care in Migraine Management: Current Reality vs. Ideal Practice

Care LevelCurrent RealityWhat Consensus Pathways Aim to Achieve
General PractitionerInconsistent screening, limited headache training, short appointments leading to missed or delayed diagnosisStandardized diagnostic criteria applied consistently, clear referral triggers, better patient education tools
Referral PathwayInformal or inconsistent referral criteria, patients often arrive at specialists without structured history or prior treatment recordsDefined clinical indicators for referral, structured information transfer between care levels
Specialist / Headache CenterReceives underprepared referrals, duplicates diagnostic work, delayed access for patients with complex diseaseFocuses on complex and refractory cases, receives well-documented referrals, reduces time to appropriate treatment initiation
Patient ExperienceYears of suboptimal treatment, progression from episodic to chronic migraine, frustration and disengagementEarlier correct diagnosis, matched treatment intensity, reduced disease progression risk

Historical Context: Decades of Effort to Standardize Migraine Care

The Italian initiative did not emerge in a vacuum. It represents the latest chapter in decades of international effort to create structure around migraine diagnosis and management. The International Headache Society published the first International Classification of Headache Disorders in 1988, providing a shared diagnostic language that transformed how migraine was understood and studied. Subsequent editions refined and expanded this framework, and today the ICHD criteria are used globally to define and categorize headache disorders.

Major clinical guidelines from organizations including the European Headache Federation and the American Headache Society have periodically updated treatment recommendations as new evidence and new drug classes — most notably the calcitonin gene-related peptide (CGRP) inhibitors, a new generation of migraine-specific preventive therapies — have entered the field. Yet translating these international guidelines into national practice, and from specialist practice into primary care, has been a persistent challenge.

Italy's healthcare system, like those of many European countries, is organized in a way that places GPs as gatekeepers to specialist care. This structure can work well when GP training and referral pathways are well-calibrated to the disease in question — but for migraine, that calibration has often been lacking. National consensus efforts, like the one described here, serve a practical function that international guidelines cannot: they speak directly to the specific organizational realities of a given healthcare system and can translate global evidence into locally implementable guidance.

What Optimized Migraine Care Looks Like in Practice

While the specific recommendations of the Italian consensus document are beyond the scope of what the published abstract describes in full, the framework it aims to establish reflects well-established principles of optimized headache management that have been validated in international research and clinical experience.

Structured Diagnosis at the First Point of Contact

Effective migraine care begins with accurate diagnosis, and accurate diagnosis requires that primary care practitioners have both the knowledge and the tools to recognize migraine when it presents. This means familiarity with ICHD diagnostic criteria, awareness of migraine's wide phenotypic variability — including migraine without aura, migraine with aura, and vestibular migraine — and the use of validated screening instruments that can be completed quickly in a primary care setting.

Stratified Treatment Matching Treatment to Disease Severity

Not all migraine requires the same level of treatment intensity. Evidence supports a stratified care model, in which treatment is matched to the frequency and severity of attacks, the degree of disability, and the patient's prior treatment history. A person with infrequent, mild-to-moderate attacks may be well managed with acute therapies in primary care. A person with frequent, disabling attacks — particularly those occurring more than four days per month — is likely a candidate for preventive treatment, a category that until recently required specialist initiation but that is increasingly being explored in primary care settings.

Clear Criteria for When to Escalate to Specialist Care

Perhaps the most operationally important element of the Italian consensus is the effort to define when a patient should be referred from primary to specialist care. Generally accepted indications for specialist referral include: uncertainty about the diagnosis, particularly when secondary headache causes need to be excluded; failure to respond to two or more acute treatment classes; high attack frequency meeting criteria for preventive therapy consideration; and suspected or confirmed medication overuse headache. Formalizing these criteria — and communicating them clearly to GPs — can meaningfully reduce both under-referral and unnecessary over-referral.

The Role of the Patient in Bridging the Gap

A recurring theme in migraine care research is that patients themselves often hold important information that the healthcare system fails to capture. Attack frequency, headache characteristics, associated symptoms, triggers, medication use, and the degree of functional impairment are all clinically relevant — and they are most accurately recorded by the patient over time, not reconstructed retrospectively in a medical appointment.

Headache diaries — whether paper-based or via smartphone apps — are one of the most consistently recommended tools in migraine management. They allow patients to track their experience systematically, provide clinicians with a more complete and objective picture of the disease, and support more accurate diagnosis and treatment decisions. Yet headache diary use remains low in many populations, partly because patients are not routinely advised to keep one, and partly because the handoff of that information between care levels is not standardized.

The Italian consensus initiative's focus on optimizing the patient journey implicitly includes the role of patient engagement and self-monitoring as components of effective care. Systems that empower patients to participate actively in documenting their condition tend to produce better diagnostic clarity and more appropriate treatment escalation.

Clinical Perspective: What This Means for How Migraine Is Treated

From a clinical standpoint, the Italian consensus initiative reflects a recognition that improving migraine outcomes requires systemic change, not just better drugs. The therapeutic landscape for migraine has advanced considerably in recent years, particularly with the introduction of CGRP-targeting therapies — a class of biologics that specifically prevents migraine by blocking a key pain signaling molecule. These treatments represent a genuine advance for patients with chronic or high-frequency episodic migraine who have not responded to older preventive options.

But these treatments cannot help patients who never receive a correct diagnosis, who are not identified as candidates for preventive therapy, or who cannot navigate a referral pathway to the specialists who prescribe them. The practical bottleneck in migraine management is not primarily pharmacological — it is organizational. That is precisely the gap that consensus-based care pathway initiatives are designed to address.

Neurologists and headache specialists who participate in these consensus efforts bring their clinical knowledge to bear on a problem that extends beyond their own practice walls. By helping to define what primary care practitioners should do — and when they should hand off — specialists effectively extend the reach of evidence-based migraine care into settings where most patients first seek help.

What This Research Doesn't Yet Answer

What This Consensus Initiative Doesn't Tell Us

As a consensus document rather than a randomized controlled trial, this initiative produces recommendations based on expert agreement and available evidence — not on prospective outcome data. It cannot demonstrate, on its own, that implementing these pathways will improve patient outcomes. That question requires implementation research: studies that apply the consensus recommendations in real healthcare settings and track whether patients receive faster, more accurate diagnoses, progress less often to chronic migraine, and report better quality of life. Additionally, consensus processes can be influenced by the composition of the expert panel, the methods used to resolve disagreement, and the representativeness of the participating institutions. The degree to which these recommendations will translate effectively across Italy's varied regional healthcare contexts — or to other countries' healthcare systems — remains to be tested. The abstract also does not specify what patient populations were considered, whether the framework accounts for underserved or rural populations, or how the recommendations will be communicated and implemented in everyday primary care practice.

The Road Ahead: Turning Consensus Into Practice

The real test of any consensus initiative is not its production but its uptake. Medical guidelines and consensus documents have a mixed track record in changing clinical behavior. Implementation requires more than publication: it requires education, reminder systems, incentive structures, and ongoing audit to determine whether recommendations are being followed and whether they are producing measurable improvements in care.

In Italy's context, implementation will likely require engagement with primary care physicians' professional organizations, integration into GP training programs, and potentially structural support — such as telemedicine consultation pathways between GPs and headache specialists — that make the recommended care behaviors feasible within the practical constraints of a primary care practice.

There is also the question of patient education. One of the most durable barriers in migraine care is the tendency of patients themselves to minimize their symptoms, to delay seeking care, or to accept inadequate treatment because they have never been told that better options exist. Consensus initiatives that reach patients directly — through public communication campaigns or patient advocacy partnerships — can help shift the cultural framing of migraine from a personal inconvenience to a legitimate medical condition deserving of systematic attention.

More broadly, Italy's effort may serve as a model for similar initiatives in other countries grappling with the same organizational failure. The underlying problem — that migraine is common, often disabling, usually underdiagnosed, and frequently mismanaged despite the availability of effective treatments — is not specific to any one healthcare system. Sharing consensus frameworks, implementation strategies, and outcome data across national borders could accelerate progress in closing the global migraine care gap.

What This Means for You

If you have recurring headaches that interfere with your daily life, the research landscape described here has direct implications for how you navigate the healthcare system. The key insight from the Italian consensus initiative — and from the broader migraine management literature it reflects — is that the burden of getting good care should not fall entirely on you as a patient. But knowing how the system is supposed to work, and advocating for yourself within it, can make a meaningful difference while better systems are being built.

Start by tracking your headaches systematically. A diary that records attack frequency, duration, severity, associated symptoms, and any medications used is one of the most valuable tools you can bring to any medical appointment. It transforms a subjective complaint into objective data that clinicians can use to make better diagnostic and treatment decisions. Several validated headache diary apps are available for this purpose.

If you are currently being managed for headaches in primary care and treatments are not working, or if your headaches are occurring frequently, it may be worth asking your GP about referral to a neurologist or dedicated headache clinic. Effective preventive treatments do exist, but they are often underutilized — in part because patients are not always told they are candidates.

Questions to Bring to Your Next Appointment

Whether you see a GP or a specialist, these questions can help you advocate for a more structured, evidence-based approach to your migraine care.

  • Do my symptoms meet the diagnostic criteria for migraine, or could something else be causing my headaches?
  • How often do my headaches need to occur before preventive treatment is worth considering?
  • Should I be referred to a neurologist or headache specialist given my current symptoms and treatment history?
  • Am I at risk of developing chronic migraine, and what can I do to reduce that risk?
  • What information should I be tracking between now and my next appointment to help us make better treatment decisions?
  • Are there newer treatments — including CGRP inhibitors — that might be appropriate for my level of migraine frequency and severity?
Medical Citation

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Sources & References

  1. Barbanti P, Tassorelli C, Vernieri F, De Cesaris F, De Icco R, Di Lorenzo C, Finocchi C, Grazzi L, Guerzoni S, Mampreso E, Mastronuzzi T, Messina R, Ornello R, Rao R, Taddeo D, De Tommaso M, Rainero I. "Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy." - Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2026)

Medical Disclaimer: The information provided on ChronicRelief.org is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.